Adaptive Biotechnologies Corp (ADPT NASDAQ) stock market data APIs
$26.9056
0.26(1%)
as of October 30, 2026
Try our APIs with
free plan!
Adaptive Biotechnologies Corp Financial Data Overview
Price chart is built with
Anychart
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunosequencing platform which combines a suite of proprietary chemistry, computational biology, and machine learning to generate clinical immunomics data to decode the adaptive immune system. It provides clonoSEQ diagnostic test which detects and monitors the remaining number of cancer cells that are present in a patient's body during and after treatment, known as Minimal Residual Disease (MRD). The company offers products and services for life sciences research, clinical diagnostics, and drug discovery applications. The company was formerly known as Adaptive TCR Corporation and changed its name to Adaptive Biotechnologies Corporation in December 2011. Adaptive Biotechnologies Corporation was incorporated in 2009 and is headquartered in Seattle, Washington.
Prev. Close
26.9056
Open
27.163
High
27.8204
Low
26.1695
52 wk Range
12-30.74
Market Cap
4 252 M
Shares Outstanding
160 M
Revenue
308 M
Beta
2.096
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Adaptive Biotechnologies Corp (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Adaptive Biotechnologies Corp data using free add-ons & libraries
Get Adaptive Biotechnologies Corp Fundamental Data
Adaptive Biotechnologies Corp Fundamental data includes:
- Net Revenue: 308 M
- EBITDA: -21 327 000
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
Get Adaptive Biotechnologies Corp Earnings data
Corporate Events Calendar & News package for
$
19.99
/mo.
What’s included:
- Latest Release: 2026-11-04
- EPS/Forecast: -0.1
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Adaptive Biotechnologies Corp News
New
TELO Genomics Expands Multi-Center Clinical Studies to Advance Comparative Validation of TELO-MRD Against Next-Generation Sequencing
In matched multi-center cohorts, Telo Genomics is expanding comparative evaluation of blood-based TELO-MRD against Adaptive Biotechnologies' clonoSEQ next-generation sequencing MRD testing. Vancouver...
Adaptive Biotechnologies Corp. (ADPT) Rallies on Earnings Beat, Raised Outlook, and Cash-Flow Targets
Fred Alger Management, an investment management company, released its third-quarter 2026 investor letter for "Alger Small Cap Growth Fund". The letter can be downloaded here. U.S. equities rose modest...
Adaptive Biotechnologies to Report Third Quarter 2026 Financial Results on November 4, 2026
Adaptive Biotechnologies SEATTLE, Oct. 14, 2026 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics o...
Adaptive Biotechnologies (ADPT) Stock Sees Modest Fair Value Lift On MRD Optimism
Adaptive Biotechnologies now sits on a higher modeled fair value, with the price target moving from US$26.36 to US$28.31 per share. This shift reflects how analysts are weighing strong enthusiasm arou...
Get Adaptive Biotechnologies Corp fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
Best Offer
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.